Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
暂无分享,去创建一个
C. Reddy | T. Djemil | G. Videtic | Michael J. Burdick | S. Srinivas | K. Stephans | Toufik Djemil | Michael J. Burdick | Kevin L. Stephans | Chandana A. Reddy | Shyam M. Srinivas | Gregory M.M. Videtic
[1] Sasa Mutic,et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[2] H. Kato,et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.
[3] K. Ishikawa,et al. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer--a multicenter study. , 2005, Lung cancer.
[4] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[5] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[6] T. Naruke,et al. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma , 2006, Cancer.
[7] D. Galetta,et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] O. Warburg. On the origin of cancer cells. , 1956, Science.
[9] T. Rice,et al. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. , 2008, International journal of radiation oncology, biology, physics.
[10] F. Gao,et al. Prognostic Value of Preoperative Positron Emission Tomography in Resected Stage I Non-small Cell Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] R. Timmerman,et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. , 2005, Lung cancer.
[12] D. Wood,et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] K. Hiroshima,et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] I. Lax,et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. , 2003, Lung cancer.
[15] T. Naruke,et al. Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma , 2006, Cancer.
[16] Y. Liu,et al. 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer. , 2007, Chinese medical journal.
[17] J. Beitler,et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. , 2006, International journal of radiation oncology, biology, physics.
[18] R. Timmerman,et al. Stereotactic Body Radiation Therapy: A Comprehensive Review , 2007, American journal of clinical oncology.
[19] W. Oyen,et al. Prognostic Value of Different Metabolic Measurements with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Resectable Non-Small Cell Lung Cancer: A Two-Center Study , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] Yukiko Arisaka,et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] C. Dooms,et al. Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer. , 2004, Chest.
[22] J. Sunderland,et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1992, Radiology.
[23] J. Wong,et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.
[24] R Iwata,et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] Edward Clouser,et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. , 2010, International journal of radiation oncology, biology, physics.
[26] M Hatanaka,et al. Transport of sugars in tumor cell membranes. , 1974, Biochimica et biophysica acta.
[27] E. Hall,et al. Radiobiology for the radiologist , 1973 .
[28] L V Rubinstein,et al. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.
[29] Y. Yatabe,et al. Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer--from studies of 604 surgical cases. , 2007, Lung cancer.
[30] C. Franzius. FDG PET: advantages for staging the mediastinum? , 2004, Lung cancer.
[31] M S Pepe,et al. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.
[32] Ludy Lutgens,et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. , 2005, International journal of radiation oncology, biology, physics.
[33] D. Wood,et al. Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation Index , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[34] N. Altorki,et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. , 2007, The Annals of thoracic surgery.